Fabian Meili
Novartis (United States)(US)
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Fungal and yeast genetics research, RNA and protein synthesis mechanisms, CRISPR and Genetic Engineering, Autism Spectrum Disorder Research
Most-Cited Works
- → Systematic phenomics analysis of autism-associated genes reveals parallel networks underlying reversible impairments in habituation(2019)82 cited
- → DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance(2024)76 cited
- → Multi-model functionalization of disease-associated PTEN missense mutations identifies multiple molecular mechanisms underlying protein dysfunction(2020)63 cited
- → A Forward Genetic Screen and Whole Genome Sequencing Identify Deflagellation Defective Mutants inChlamydomonas, Including Assignment of ADF1 as a TRP Channel(2016)24 cited
- → Multi-parametric analysis of 57 SYNGAP1 variants reveal impacts on GTPase signaling, localization, and protein stability(2020)20 cited
- → A Premalignant Cell-Based Model for Functionalization and Classification of PTEN Variants(2020)17 cited
- → Sentinel interaction mapping – a generic approach for the functional analysis of human disease gene variants using yeast(2020)7 cited
- → Multi-model functionalization of disease-associated PTEN missense mutations identifies multiple molecular mechanisms underlying protein dysfunction(2019)2 cited
- → Systematic phenomics analysis of ASD-associated genes reveals shared functions and parallel networks underlying reversible impairments in habituation learning(2019)2 cited
- → Author Correction: DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance(2024)1 cited